Clinical Trial: A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07576868) titled 'A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)' on April 27.

Brief Summary: This is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients with dengue infection.

Study Start Date: April 09

Study Type: INTERVENTIONAL

Condition: Dengue

Intervention: DRUG: CP-COV03

Oral administration

DRUG: Placebo

Oral administration

Recruitment Status: RECRUITING

Sponsor: Hyundai Bioscience Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....